BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?

Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil

(2016) Simone Maistro et al.   BMC CANCER

Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study

(2016) Jacopo Azzollini et al.   European Journal of Internal Medicine

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer

(2016) Nadine Tung et al.   JOURNAL OF CLINICAL ONCOLOGY

Analysis of protein-coding genetic variation in 60,706 humans

(2016) Monkol Lek et al.   NATURE

Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations

(2016) Bárbara Alemar et al.   Cancer Genetics

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions

(2015) Johnathan M. Lancaster et al.   GYNECOLOGIC ONCOLOGY

A global reference for human genetic variation

(2015) Richard A. Gibbs et al.   NATURE

Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients

(2014) Felipe C Silva et al.   BMC Medical Genetics

American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology Providers

(2014) Karen H. Lu et al.   JOURNAL OF CLINICAL ONCOLOGY

MutationTaster2: mutation prediction for the deep-sequencing age

(2014) Jana Marie Schwarz et al.   NATURE METHODS

PredictSNP: Robust and Accurate Consensus Classifier for Prediction of Disease-Related Mutations

(2014) Jaroslav Bendl et al.   PLoS Computational Biology

Admixture in Latin America: Geographic Structure, Phenotypic Diversity and Self-Perception of Ancestry Based on 7,342 Individuals

(2014) Andrés Ruiz-Linares et al.   PLoS Genetics

Comprehensive Analysis of BRCA1, BRCA2 and TP53 Germline Mutation and Tumor Characterization: A Portrait of Early-Onset Breast Cancer in Brazil

(2013) Dirce Maria Carraro et al.   PLoS One

Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management

(2012) Simone Heidemann et al.   BREAST CANCER RESEARCH AND TREATMENT

Familial Breast Cancer

(2012) F Lalloo et al.   CLINICAL GENETICS

Cancer Risk Management Decisions of Women with BRCA1 or BRCA2 Variants of Uncertain Significance

(2011) Kaylene Ready et al.   Breast Journal

SEOM clinical guidelines for hereditary cancer

(2011) Begoña Graña et al.   Clinical & Translational Oncology

On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations

(2010) Nancy Hamel et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA